Clinical trial
Paroxetine in the Treatment of Chronic Primary Insomnia
NCT00178048 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00178048 |
|---|---|
| Title | Paroxetine in the Treatment of Chronic Primary Insomnia |
| Official title | Paroxetine in the Treatment of Chronic Primary Insomnia: A Double-Blind, Randomized, Placebo-Controlled Study of Efficacy Over Six Weeks |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Primary Insomnia, Depression |
| Intervention type | Drug |
| Interventions | paroxetine |
| Enrollment | 66 |
| Start date | Sep 1, 1998 |
| Completion | Dec 1, 2003 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 15, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: